Polyrizon Ltd. Ordinary Shares

PLRZ

Polyrizon Ltd. is a biotechnology company specializing in the development of advanced antimicrobial and anti-viral solutions. The company focuses on innovative technologies aimed at enhancing hygiene and preventing the spread of infectious diseases. Through its research and development efforts, Polyrizon aims to create effective, safe, and sustainable health products for various applications.

$11.05 -0.85 (-7.69%)
🚫 Polyrizon Ltd. Ordinary Shares does not pay dividends

Company News

Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray
GlobeNewswire Inc. • Tomer Izraeli • December 8, 2025

Polyrizon successfully completed a pre-submission meeting with the FDA regarding its PL-14 Allergy Blocker nasal spray, discussing development plans, manufacturing, and clinical trial strategies for a potential product targeting the growing global allergen blocker market.

US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert
Benzinga • Rishabh Mishra • May 5, 2025

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Investors will keep an eye on the Federal Reserve's decision on interest rates this week. Analysts say any de-escalation in trade tensions should be positive for the economy and financial markets.

Related Companies